These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 3289079)
41. Rates of bone loss in the appendicular and axial skeletons of women. Evidence of substantial vertebral bone loss before menopause. Riggs BL; Wahner HW; Melton LJ; Richelson LS; Judd HL; Offord KP J Clin Invest; 1986 May; 77(5):1487-91. PubMed ID: 3700651 [TBL] [Abstract][Full Text] [Related]
43. [Strontium ranelate: a novel concept for the treatment of osteoporosis]. Dimai HP Wien Klin Wochenschr; 2005 Nov; 117(21-22):728-38. PubMed ID: 16416353 [TBL] [Abstract][Full Text] [Related]
44. [Value and limitations of the computed x-ray tomographic measurement of vertebral mineralization]. Laval-Jeantet AM; Laval-Jeantet M; Roger B; Scott C; Delmas PF J Radiol; 1984 Mar; 65(3):151-7. PubMed ID: 6716345 [TBL] [Abstract][Full Text] [Related]
45. Cortical bone mineral density versus cortical thickness in the diagnosis of osteoporosis: a roentgenologic-densitometric study. Meema HE; Meema S J Am Geriatr Soc; 1969 Feb; 17(2):120-41. PubMed ID: 5763688 [No Abstract] [Full Text] [Related]
46. Femoral trabecular-pattern index and bone mineral content measurement by photon absorption in senile osteoporosis. Khairi MR; Cronin JH; Robb JA; Smith DM; Johnston CC J Bone Joint Surg Am; 1976 Mar; 58(2):221-6. PubMed ID: 1254626 [TBL] [Abstract][Full Text] [Related]
47. Role of RANK ligand and denosumab, a targeted RANK ligand inhibitor, in bone health and osteoporosis: a review of preclinical and clinical data. Dempster DW; Lambing CL; Kostenuik PJ; Grauer A Clin Ther; 2012 Mar; 34(3):521-36. PubMed ID: 22440513 [TBL] [Abstract][Full Text] [Related]
48. Comparison of vertebral and peripheral mineral losses in disuse osteoporosis in monkeys. Cann CE; Genant HK; Young DR Radiology; 1980 Feb; 134(2):525-9. PubMed ID: 6766220 [TBL] [Abstract][Full Text] [Related]
49. [New developments in bone density measurement by quantitative computer tomography]. Kalender WA Radiologe; 1988 Apr; 28(4):173-8. PubMed ID: 3289082 [TBL] [Abstract][Full Text] [Related]
50. Quantitative computed tomography assessment of spinal trabecular bone. I. Age-related regression in normal men and women. Firooznia H; Golimbu C; Rafii M; Schwartz MS; Alterman ER J Comput Tomogr; 1984 Apr; 8(2):91-7. PubMed ID: 6713932 [TBL] [Abstract][Full Text] [Related]
51. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 9. Calcitonin in the treatment of osteoporosis. Siminoski K; Josse RG CMAJ; 1996 Oct; 155(7):962-5. PubMed ID: 8837547 [TBL] [Abstract][Full Text] [Related]
52. Bone mineral content in early-postmenopausal and postmenopausal osteoporotic women. Mazess RB Radiology; 1987 Oct; 165(1):289-91. PubMed ID: 3628787 [No Abstract] [Full Text] [Related]
53. Trabecular mineral content of the spine in women with hip fracture: CT measurement. Firooznia H; Rafii M; Golimbu C; Schwartz MS; Ort P Radiology; 1986 Jun; 159(3):737-40. PubMed ID: 3704152 [TBL] [Abstract][Full Text] [Related]
54. Changes in bone histomorphometry and bone mineral during treatment of osteoporosis with 1 alpha-hydroxyvitamin D3 and calcium. Lindholm TS; Nilsson OS; Elmstedt E; Eriksson SA; Lindholm TC; Kyhle BR Acta Vitaminol Enzymol; 1981; 3(3):170-6. PubMed ID: 7347489 [TBL] [Abstract][Full Text] [Related]
55. Bone densitometry as an adjunct to GnRH agonist therapy. Cann CE J Reprod Med; 1998 Mar; 43(3 Suppl):321-30. PubMed ID: 9564668 [TBL] [Abstract][Full Text] [Related]
57. Osteoporosis and amenorrhea in young women. Glazener CM; Sargood AJ; Jackson PC; Staddon GE; Bryan GJ; Davies ER; Hartog M; Hull MG Gynecol Endocrinol; 1987 Sep; 1(3):255-61. PubMed ID: 3503484 [TBL] [Abstract][Full Text] [Related]
58. [A guide for osteoporosis management]. Zárate A; Saucedo R; Basurto L Gac Med Mex; 2004; 140(2):235-40. PubMed ID: 15162957 [TBL] [Abstract][Full Text] [Related]
59. Importance of alfacalcidol in clinical conditions characterized by high rate of bone loss. Reginster JY; Lecart MP; Richy F J Rheumatol Suppl; 2005 Sep; 76():21-5. PubMed ID: 16142847 [TBL] [Abstract][Full Text] [Related]